General Information of DTT (ID: TTH30UI)

DTT Name Casein kinase I delta (CSNK1D) DTT Info
Gene Name CSNK1D

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Preclinical Drug(s)
Investigative Drug(s)
4 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
D-4476 DMHD3R8 Chronic lymphocytic leukaemia 2A82.0 Preclinical [1]
IC261 DMXB95R Pancreatic cancer 2C10 Preclinical [2]
PF-4800567 DM8P9ST Chronic lymphocytic leukaemia 2A82.0 Preclinical [3]
PF-670462 DMTJBP9 Chronic lymphocytic leukaemia 2A82.0 Preclinical [4]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID24900428C14 DMU4BL2 Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007 Dec 15;408(3):297-315.
2 Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem. 2000 Jun 30;275(26):20052-60.
3 Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. J Pharmacol Exp Ther. 2009 Aug;330(2):430-9.
4 Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. Blood. 2018 Mar 15;131(11):1206-1218.
5 Structure-Based Design of Potent and Selective CK1gamma Inhibitors. ACS Med Chem Lett. 2012 Oct 18;3(12):1059-64.